Oncopeptides AB (publ), a biotech company specializing in difficult-to-treat cancers, today announces data from the first patients in its ongoing clinical Window-of-Opportunity (WoO) study, OP-701 ...

Dr. Sandeep Kunwar explained that getting drugs into the brain is a major hurdle for glioblastoma, as the blood-brain barrier blocks most treatments. Dr. Sandeep Kunwar, a neurosurgeon and professor ...

The wins in brain conditions like Alzheimer's, Huntington's and Parkinson's disease are beginning to stack up. But one major challenge still stands in the way of many promising treatments: the ...

The endothelial cells lining the blood vessels of your brain are stitched together so tightly that the gaps between them measure roughly 4 nanometers — about the width of a strand of DNA, and small ...

Newswise — JACKSONVILLE, Fla. — Mayo Clinic researchers developed an experimental nanotherapy that delivers two cancer drugs directly to brain tumors, according to a study published in Nature ...

The review examines how engineered nanoparticles and predictive tools, including PK/PD, PBPK, CFD, and AI/ML models, could ...

EQT Foundation Science Grant Researchers are pursuing multiple routes through and around the blood-brain barrier, including engineered biological carriers, molecular shuttles, gene therapy vectors, ...

London's ExCeL center opened AAIC 2026 this morning with the most consequential claim the Alzheimer's field has heard in years: the blood-brain barrier — the endothelial wall that has blocked every ...

STOCKHOLM - October 9, 2026 - Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company specializing in difficult-to-treat cancers, today announces data from the first patients in its ongoing ...